ResearcherKarolinska University HospitalActive in the last 2 years
Ebba Asplund
Matched on ORCID iD 0000-0002-7649-7901; OpenAlex author ID A5060148877. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2023: 1 paper · 2024: 1 paper · 2025: 1 paper
Papers 3
- Exploring the psychological burden in a pancreatic cancer surveillance programme based on high-risk individuals: a Swedish cross-sectional study. First author DOI 10.1136/bmjopen-2024-097814↗
- Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer. Co-author DOI 10.1158/2767-9764.crc-23-0405↗
- Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospective study. Co-author DOI 10.1080/00365521.2023.2198057↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthias J. Löhr · 3 shared papers, 2023–2025 · strength 0.76
- Paper Exploring the psychological burden in a pancreatic cancer surveillance programme based on high-risk individuals: a Swed… DOI 10.1136/bmjopen-2024-097814↗
- Paper Plasma thymidine kinase activity as a prognostic biomarker in pancreatic ductal adenocarcinoma: a single-center prospec… DOI 10.1080/00365521.2023.2198057↗
- Paper Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cance… DOI 10.1158/2767-9764.crc-23-0405↗
- Miroslav Vujasinović · 1 shared paper, 2025 · strength 0.28
- Anna Vesterberg · 1 shared paper, 2025 · strength 0.28
- Carlos Fernández Moro · 1 shared paper, 2024 · strength 0.21
- Helen Kaipe · 1 shared paper, 2024 · strength 0.21
- Laia Gorchs · 1 shared paper, 2024 · strength 0.21
- Ernesto Sparrelid · 1 shared paper, 2024 · strength 0.21
- Poya Ghorbani · 1 shared paper, 2024 · strength 0.21
- Elena B. Rangelova · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.